< previous page	page_57	next page >
Page 57 Dollars in millions Company Year of incorporation Total assets 1992 Total sales 19871992 R&D 19871992 Abbott 1888 $6,499.1 $36,077.4 $3,358.4 Allergan 1948 829.4 4,011.5 363.5 American Home Products 1926 6,686.6 41,586.8 2,364.0 Baxter 1931 8,571.9 37,854.6 1,350.5 Bristol-Myers Squibb 1900 10,115.9 57,811.4 5,041.7 Carter-Wallace 1880 562.3 3,581.4 271.4 Eli-Lilly 1876 8,120.4 28,418.3 3,986.5 Glaxob 1935 9,629.0 30,052.0 3,839.2 Johnson & Johnson 1887 11,127.1 65,124.9 5,013.9 Marion Merrell Dow 1950 2,980.3 10,099.8 1,439.5 Merck 1891 10,379.9 44,020.2 4,996.1 Novo Nordiskb 1940 2,615.1 7,563.7 980.0 Pfizer 1849 8,979.3 37,208.2 3,698.5 Rhone-Poulenc Rorer 1910 3,612.6 13,847.1 1,599.3 Schering-Plough 1908a 3,891.9 20,180.2 2,226.2 SmithKline Beechamb 1830 4,508.3 42,015.2 3,590.1 Syntex 1957 2,630.2 9,290.6 1,616.1 Upjohn 1886 4,311.6 18,099.1 2,652.8 Warner-Lambert 1920 3,817.7 27,320.8 2,096.5 Wellcomeb 1880 3,349.3 15,267.4 2,121.6 Total $113,218.1 $549,430.2 $52,605.7 Note: All amounts equal to 1990 dollars. Annual data were not available for some years. aSchering-Plough was reorganized in 1970. bAmounts calculated using average exchange rate for given year. All amounts, except Novo-Nordisk's R&D, taken from Compact Disclosure. Source: Corporate annual reports and SEC 10K reports. Fig. 2 Information on the top 20 pharmaceutical companies for years 1987 through 1992, assets as of 1992.
< previous page	page_57	next page >